Allogeneic Peripheral Blood Stem Cell Transplantation

Authors

  • Samart Pakakasama หน่วยโลหิตวิทยาและมะเร็งในเด็ก ภาควิชากุมารเวชศาสตร์ คณะแพทยศาสตร์โรงพยาบาลรามาธิบดี มหาวิทยาลัยมหิดล

Keywords:

-

Abstract

-

Downloads

Download data is not yet available.

References

Korbling M, Huh YO, Durett A, et al. Allogeneic blood stem cell transplantation: Peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34* Thy-1dim) and lymphoid subsets, and possible predictions of engraftment and graft-versus-host disease. Blood 1995,86:2842-8.

Korbling M, Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?. Blood 2001,98:2900-8.

Ottinger HD, Beelen DW, Scheulen B, et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996:88:2775-9.

Anderlini P, Rezzo JD, Nugent ML, et al. Peripheral blood stem cell donation: an analysis from the International Bone Marrow transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant 2001;27:689-92.

Strancek DF, Holland PV, Bartch G, et al. Experiences of the first 493 unrelated marrow donors in the National Marrow Donor program. Blood 1993;81:1940-6.

Cavallaro AM, Lilleby K, Majolino I, et al. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 2000;25:85-9.

Anderlini P, Korbling M, Dale D, et al. Allogeneic blood stem cell transplantation: Consideration for donors. Blood 1997;90:903-8.

Vigorito AC, Azevedo WM, Marques JFC, et al. A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. Bone Marrow Transplant 1998;22:1145-51.

Ringden O, Remberger M, Runde V, et al. Peripheral blood stem cell transplantation from unrelated donors: A comparison with marrow transplantation. Blood 1999;94:455-64.

Blaise D, Kuentz M, Fortanier C, et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 2000;18:537-46.

Heldal D, Tjonnfiord G, Brinch L, et al. A randomised study of allogeneic transplantation with stem cells from blood or bone marrow. Bone Marrow Transplant 2000:25:1129-36.

Powles R, Mehta J, Kulkarni S, et al. Allogeneic blood and bone-marrow stem cell transplantation in haematological malignant diseases: a randomised trial. Lancet 2000;355:1231-7.

Champlin RE, Schmitz N, Horowitz MM, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood 2000;95:3702-9.

Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001,344:175-81.

Couban S, Simpson DR, Barnett MJ, et al. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 2002;100:1525-31.

Downloads

Published

2022-12-30

Issue

Section

บทบรรณาธิการ (Editorial)